Background Colony-stimulating factor 1 receptor (CSF1R)–dependent monocytes and
macrophages are key mediators of chronic graft-versus-host disease (GVHD), a major long …

Objectives Authors assessed the impact of ruxolitinib (RUX) on steroid-refractory graft-
versus-host disease (SR-GVHD) patients. Methods Studies published before January 2019 …

Purpose The survival rates of patients undergoing allogeneic hematopoietic stem cell
transplantation (HSCT) have improved. However, HSCT can induce significant long-term …

Background Chronic graft‐versus‐host disease (GVHD) is a potentially life‐threatening
complication of allogeneic hematopoietic stem cell transplantation (HSCT) treatment for …

Purpose To investigate pathological changes in blood vessels and meibomian glands (MGs)
in the eyelids of sclerodermatous chronic graft-versus-host disease (cGVHD) model mice …

Simple Summary Patients who have been treated with an allogeneic, hematopoietic stem
cell transplantation can develop severe graft-versus-host disease. This complication may …

Introduction Chronic graft-versus-host disease (cGVHD) is a serious immune-mediated
complication after allogeneic haematopoietic stem cell transplantation (HSCT), but in …

Background Chronic graft-versus-host disease (cGVHD) is a debilitating late complication of
hematopoietic stem cell transplantation. It is often accompanied by extensive symptom …

Chronic graft versus host disease (cGVHD) is a debilitating and costly complication following
haemopoietic stem cell transplantation (HSCT). This study describes the economic burden …

慢性移植物抗宿主病患者生活质量评估及其差异研究- PMC Back to Top Skip to main content
NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …